MGRX Mangoceuticals, Inc. stock chart & analysis
Conviction 40Scan · Wed, Nov 18, 2026Mangoceuticals, Inc. (MGRX) closed at $0.1461 (-8.69%) on Nov 18, 2026. Price is below its 50-day and below its 200-day moving average. RSI(14) 25, RS Rating 4, -89.4% from its 52-week high, -80.3% year to date. Sector: Services-Misc Health & Allied Services, NEC.
Why MGRX moved
From the StockSetups movers recaps that covered MGRX, newest first. A recap states what was known that day.
- Premarket+35.1%
The catalyst is well-documented. According to Benzinga, Yahoo Finance, GlobeNewswire, and The Globe and Mail, Mangoceuticals' planned merger partner — Nuclea Energy — has executed an MOU (Memorandum of Understanding) with the Utah Office of Energy Development to explore a Morpheus test-reactor site.
Premarket Stock Movers — August 6, 2026: Why WYHG, PAVS, ENSC, CELZ & MGRX Are Surging →
Financials as of Wed, Sep 30, 2026 · quarterly.
MGRX technical analysis
Trend
MGRX is in a downtrend: price is below the 50-day, which is below the 200-day moving average. It closed 55.2% below the 50-day ($0.3261) and 62.3% below the 200-day ($0.3876). ADX(14) at 50 points to a strong, established trend. It meets 0 of 8 trend-template criteria.
Momentum
RSI(14) is 25, in oversold territory. MACD crossed above its signal line one session ago. Its RS Rating of 4 puts its weighted 12-month performance ahead of about 4% of the US market.
Volume and volatility
It trades about $171,601 a day on average. ATR(14) is $0.0299, 20.5% of price — its typical daily range. On-balance volume is trending down. Chaikin Money Flow (-0.41) shows distribution.
Key levels
The chart pattern's support is $0.1673 and its resistance $0.4990. The 52-week range is $0.1446 to $1.38; price is 89.4% below the high and 1.0% above the low. The VWAP anchored at the 52-week high is $0.5465, above price.
Performance
MGRX returned -26.7% (1 week), -51.3% (1 month), -62.1% (3 months), -65.8% (6 months), -88.4% (1 year), -80.3% (year to date).
About Mangoceuticals, Inc.
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Services-Misc Health & Allied Services, NEC · Listed 2023
SEC filings
EDGAR filings in MGRX · 10 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, no credit card.
Start free — 7-day trial, no card →Free daily signals by email. Top 3 setups per lane after every close. No account needed.
Unsubscribe anytime · Privacy
Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.